Cargando…
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776258/ https://www.ncbi.nlm.nih.gov/pubmed/32079691 http://dx.doi.org/10.3324/haematol.2019.243246 |
| _version_ | 1783630640246161408 |
|---|---|
| author | Lin, Richard J. Lobaugh, Stephanie M. Pennisi, Martina Chan, Hei Ton Batlevi, Yakup Ruiz, Josel D. Elko, Theresa A. Maloy, Molly A. Batlevi, Connie L. Dahi, Parastoo B. Giralt, Sergio A. Hamlin, Paul A. Mead, Elena Noy, Ariela Lia Palomba, M. Santomasso, Bianca D. Sauter, Craig S. Scordo, Michael Shah, Gunjan L. Korc-Grodzicki, Beatriz Kim, Soo Jung Silverberg, Mari Lynne Brooklyn, Chelsea A. Devlin, Sean M. Perales, Miguel-Angel |
| author_facet | Lin, Richard J. Lobaugh, Stephanie M. Pennisi, Martina Chan, Hei Ton Batlevi, Yakup Ruiz, Josel D. Elko, Theresa A. Maloy, Molly A. Batlevi, Connie L. Dahi, Parastoo B. Giralt, Sergio A. Hamlin, Paul A. Mead, Elena Noy, Ariela Lia Palomba, M. Santomasso, Bianca D. Sauter, Craig S. Scordo, Michael Shah, Gunjan L. Korc-Grodzicki, Beatriz Kim, Soo Jung Silverberg, Mari Lynne Brooklyn, Chelsea A. Devlin, Sean M. Perales, Miguel-Angel |
| author_sort | Lin, Richard J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7776258 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77762582021-01-07 Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma Lin, Richard J. Lobaugh, Stephanie M. Pennisi, Martina Chan, Hei Ton Batlevi, Yakup Ruiz, Josel D. Elko, Theresa A. Maloy, Molly A. Batlevi, Connie L. Dahi, Parastoo B. Giralt, Sergio A. Hamlin, Paul A. Mead, Elena Noy, Ariela Lia Palomba, M. Santomasso, Bianca D. Sauter, Craig S. Scordo, Michael Shah, Gunjan L. Korc-Grodzicki, Beatriz Kim, Soo Jung Silverberg, Mari Lynne Brooklyn, Chelsea A. Devlin, Sean M. Perales, Miguel-Angel Haematologica Letters to the Editor Fondazione Ferrata Storti 2020-02-20 /pmc/articles/PMC7776258/ /pubmed/32079691 http://dx.doi.org/10.3324/haematol.2019.243246 Text en Copyright© 2021 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letters to the Editor Lin, Richard J. Lobaugh, Stephanie M. Pennisi, Martina Chan, Hei Ton Batlevi, Yakup Ruiz, Josel D. Elko, Theresa A. Maloy, Molly A. Batlevi, Connie L. Dahi, Parastoo B. Giralt, Sergio A. Hamlin, Paul A. Mead, Elena Noy, Ariela Lia Palomba, M. Santomasso, Bianca D. Sauter, Craig S. Scordo, Michael Shah, Gunjan L. Korc-Grodzicki, Beatriz Kim, Soo Jung Silverberg, Mari Lynne Brooklyn, Chelsea A. Devlin, Sean M. Perales, Miguel-Angel Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma |
| title | Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma |
| title_full | Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma |
| title_fullStr | Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma |
| title_full_unstemmed | Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma |
| title_short | Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma |
| title_sort | impact and safety of chimeric antigen receptor t-cell therapy in older, vulnerable patients with relapsed/refractory large b-cell lymphoma |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776258/ https://www.ncbi.nlm.nih.gov/pubmed/32079691 http://dx.doi.org/10.3324/haematol.2019.243246 |
| work_keys_str_mv | AT linrichardj impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT lobaughstephaniem impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT pennisimartina impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT chanheiton impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT batleviyakup impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT ruizjoseld impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT elkotheresaa impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT maloymollya impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT batleviconniel impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT dahiparastoob impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT giraltsergioa impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT hamlinpaula impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT meadelena impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT noyariela impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT liapalombam impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT santomassobiancad impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT sautercraigs impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT scordomichael impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT shahgunjanl impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT korcgrodzickibeatriz impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT kimsoojung impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT silverbergmarilynne impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT brooklynchelseaa impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT devlinseanm impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma AT peralesmiguelangel impactandsafetyofchimericantigenreceptortcelltherapyinoldervulnerablepatientswithrelapsedrefractorylargebcelllymphoma |